Table 1.
LoVo Cells (GSE-I) | LoVo Cells (GSE-II) | |||||||
Total cell number X 105 | Total cell number X 105 | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 3.4±0.6 | 3.7±0.4 | 3.6±0.3 | 2.1±0.2* | 2.7±0.2 | 2.3±0.3 | 1.9±0.1# | 1.4±0.2$ |
24h | 9.6±1.0 | 8.3±1.3 | 6.0±0.7# | 2.9±1.0$ | 4.9±0.2 | 4.3±0.7 | 3.0±0.3# | 2.0±0.2$ |
48h | 15.0±2.9 | 7.8±0.8# | 4.7±0.8$ | 1.9±0.2$ | 12.5±1.1 | 10.0±1.5 | 2.5±0.1$ | 1.9±0.4$ |
Percent Dead Cell Population | Percent Dead Cell Population | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 4.2±1.8 | 9.1±4.2 | 18.0±1.6$ | 35.0±7.4# | 3.4±0.7 | 8.2±0.2 | 21.9±0.8$ | 47.3±1.1$ |
24h | 9.8±2.4 | 12.7±1.1 | 23.6±6.3 | 56.0±15* | 5.6±1.4 | 12.0±4.1 | 30.0±2.3$ | 55.0±12# |
48h | 13.6±4.1 | 14.1±6.1 | 26.2±4.8* | 44.0±5.9* | 8.9±0.9 | 12.0±2.8 | 35.8±4.7$ | 49.4±4.7$ |
HT29 Cells (GSE-I) | HT29 Cells (GSE-II) | |||||||
Total cell number X 105 | Total cell number X 105 | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 2.4±0.5 | 1.9±0.4 | 1.6±0.3 | 1.5±0.1# | 2.0±0.2 | 1.6±0.4 | 1.7±0.3 | 1.7±0.2 |
24h | 4.0±0.34 | 4.0±0.4 | 4.0±0.6 | 2.4±0.3# | 3.3±0.2 | 2.8±0.5 | 2.2±0.3 | 1.9±0.3# |
48h | 8.0±1.4 | 8.3±1.8 | 6.5±0.2 | 3.2±0.7# | 6.4±0.2 | 5.6±0.5 | 5.0±0.4# | 1.4±0.2$ |
Percent Dead Cell Population | Percent Dead Cell Population | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 1.4±0.6 | 1.7±0.7 | 4.1±0.9 | 5.6±1.9* | 3.3±1.4 | 4.0±0.7 | 8.3±1.3* | 12.0±1.4# |
24h | 3.7±2.2 | 4.8±1.6 | 6.1±2.5 | 14.0±2.4* | 5.1±1.6 | 5.5±1.0 | 10.4±1.8 | 26.8±4.1# |
48h | 4.8±1.4 | 6.6±3.3 | 11.0±2.7 | 18.0±8.5* | 4.7±0.1 | 10.0±1.4 | 17.0±3.8# | 33.0±4.5$ |
SW480 Cells (GSE-I) | SW480 Cells (GSE-II) | |||||||
Total cell number X 105 | Total cell number X 105 | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 1.2±0.1 | 1.3±0.2 | 1.3±0.1 | 1.2±0.2 | 1.2±0.1 | 0.9±0.1 | 0.9±0.1 | 0.7±0.2# |
24h | 2.0±0.3 | 2.2±0.4 | 1.9±0.5 | 1.4±0.3$ | 1.3±0.2 | 0.9±0.1 | 0.7±0.1# | 0.6±0.1$ |
48h | 3.0±0.3 | 2.0±0.1# | 1.8±0.2$ | 1.3±0.2$ | 2.2±0.4 | 0.8±0.1$ | 0.8±0.1$ | 0.7±0.1$ |
Percent Dead Cell Population | Percent Dead Cell Population | |||||||
Time | Control | 25 μg/ml | 50 μg/ml | 100μg/ml | Control | 25 μg/ml | 50 μg/ml | 100μg/ml |
12h | 2.7±2.4 | 3.4±2.4 | 6.6±2.3 | 14.0±5.3* | 4.3±0.3 | 5.4±0.6* | 16.0±4.1# | 20.5±4.2# |
24h | 4.6±1.4 | 13.2±9.2 | 11.3±6.0 | 30.0±7.0# | 3.8±0.4 | 15.0±2.6# | 29.0±4.2# | 40.0±9.6# |
48h | 4.4±0.8 | 10.0±3.6 | 15.0±0.8# | 33.6±10* | 4.2±1.1 | 14.6±3.6# | 25.4±2.2$ | 56.0±9.2$ |
The biological activity of GSE-I and GSE-II was measured in terms of their effects on total cell number and percentage of cell death. The data shown in each case are mean of three independent observations with standard deviation, and were reproducible in two additional independent experiments.
P< 0.05;
P<0.01;
P<0.001, control (DMSO) versus various GSE-I/GSE-II treatments as indicated in the Table.